Syndax Pharmaceuticals management attended conferences in Boston, London, and New York on October 30, 2026.

The entities involved

• Syndax Pharmaceuticals →

  business

  • Syndax Pharmaceuticals reported collaboration revenue derived from Niktimvo sales.Tue 07:46
  • Syndax Pharmaceuticals confirms Michael Metzger as CEO and Botwood as Chief Medical Officer.Tue 05:05
• Boston →

  capital and largest city of Massachusetts, United States

  • The recent events in Boston led to a review of the city's safety protocols.01:01
  • NIOSH is investigating a line of duty death in Boston, with Michelle Wu representing the city community.01:01
• London →

  capital and largest city of England and the United Kingdom

  • Drought conditions are forcing speed restrictions and timetable changes on the vulnerable rail line connecting London to Devon.04:28
  • Concerts are driving tourism revenue, with Spanish tourism and cruise lines expanding operations in London and Europe.01:19

Related events

• Eton Pharmaceuticals executives will present at a conference in London on November 1, 2026.Wed 23:39
• Tonix Pharmaceuticals announced it will present at a conference in Boston.Wed 14:15
• Syndax Pharmaceuticals received an award from the Galien Foundation on October 30, 2026.Fri 15:32
• Syndax Pharmaceuticals has FDA-approved therapies in its pipeline and uses LinkedIn for company communication.Jun 7
• Company management of Ascentage Pharma Group International will participate in investor conferences in London on November 3, 2026.Tue 14:38